Gian Marco Werro
SwitzerlandanalystMale7.0Global Dominance: 0.00%Gian Marco Werro is an equity analyst at Zürcher Kantonalbank, specializing in pharmaceutical and biotechnology sectors. He is known for his insightful analyses of market trends and company performance, particularly in relation to innovative treatments like Nemluvio, which has contributed significantly to Galderma's impressive growth in recent years.
Power618
Reach7,645
Country presence
Recent news mentions
Gian Marco Werro, an analyst at Zürcher Kantonalbank, commented on the potential of Nemluvio and its impact on Galderma's revenue.
Die Aktien von Galderma sind kurzfristig ausgereiztNeue Zürcher Zeitung·Switzerland· 2026-08-09
Switzerland· 2026-08-09
